These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9358913)

  • 1. Lobe of origin and histologic type of lung cancer associated with asbestos exposure in the Carotene and Retinol Efficacy Trial (CARET).
    Brodkin CA; McCullough J; Stover B; Balmes J; Hammar S; Omenn GS; Checkoway H; Barnhart S
    Am J Ind Med; 1997 Dec; 32(6):582-91. PubMed ID: 9358913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Thornquist M; Barnhart S; Balmes J; Cherniack M; Cullen M; Glass A; Keogh J; Liu D; Meyskens F; Perloff M; Valanis B; Williams J
    IARC Sci Publ; 1996; (136):67-85. PubMed ID: 8791118
    [No Abstract]   [Full Text] [Related]  

  • 3. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
    Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carotene and retinol efficacy trial: lung cancer chemoprevention trial in heavy cigarette smokers and asbestos-exposed workers. CARET Coinvestigators and Staff.
    Goodman GE; Omenn GS
    Adv Exp Med Biol; 1992; 320():137-40. PubMed ID: 1442278
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.
    Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Cherniack MG; Brodkin CA; Hammar S
    J Natl Cancer Inst; 1996 Nov; 88(21):1550-9. PubMed ID: 8901853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers.
    Omenn GS; Goodman GE; Thornquist MD; Rosenstock L; Barnhart S; Gylys-Colwell I; Metch B; Lund B
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):381-7. PubMed ID: 8348062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CARET, the beta-carotene and retinol efficacy trial to prevent lung cancer in asbestos-exposed workers and in smokers.
    Omenn GS; Goodman G; Grizzle J; Thornquist M; Rosenstock L; Barnhart S; Anderson G; Balmes J; Cherniack M; Cone J
    Anticancer Drugs; 1991 Feb; 2(1):79-86. PubMed ID: 1958856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET).
    Neuhouser ML; Patterson RE; Thornquist MD; Omenn GS; King IB; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):350-8. PubMed ID: 12692110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment for the beta-carotene and retinol efficacy trial (CARET) to prevent lung cancer in smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Grizzle J; Thornquist M; Rosenstock L; Barnhart S; Anderson G; Balmes J; Cone J; Cherniack M
    West J Med; 1992 May; 156(5):540-4. PubMed ID: 1595284
    [No Abstract]   [Full Text] [Related]  

  • 10. The association between participant characteristics and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung cancer.
    Goodman GE; Thornquist M; Kestin M; Metch B; Anderson G; Omenn GS
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):815-21. PubMed ID: 8896893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET).
    Thornquist MD; Omenn GS; Goodman GE; Grizzle JE; Rosenstock L; Barnhart S; Anderson GL; Hammar S; Balmes J; Cherniack M
    Control Clin Trials; 1993 Aug; 14(4):308-24. PubMed ID: 8365195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of lung cancer among asbestos-exposed men in the {beta}-carotene and retinol efficacy trial.
    Cullen MR; Barnett MJ; Balmes JR; Cartmel B; Redlich CA; Brodkin CA; Barnhart S; Rosenstock L; Goodman GE; Hammar SP; Thornquist MD; Omenn GS
    Am J Epidemiol; 2005 Feb; 161(3):260-70. PubMed ID: 15671258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stopping the active intervention: CARET.
    Bowen DJ; Thornquist M; Anderson K; Barnett M; Powell C; Goodman G; Omenn G;
    Control Clin Trials; 2003 Feb; 24(1):39-50. PubMed ID: 12559641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CARET asbestos-exposed cohort: baseline characteristics and comparison to other asbestos-exposed cohorts.
    Barnhart S; Keogh J; Cullen MR; Brodkin C; Liu D; Goodman G; Valanis B; Glass A; Thornquist M; Rosenstock L; Omenn G; Balmes J
    Am J Ind Med; 1997 Dec; 32(6):573-81. PubMed ID: 9358912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene.
    de Klerk NH; Musk AW; Ambrosini GL; Eccles JL; Hansen J; Olsen N; Watts VL; Lund HG; Pang SC; Beilby J; Hobbs MS
    Int J Cancer; 1998 Jan; 75(3):362-7. PubMed ID: 9455794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future.
    Omenn GS
    Eur J Cancer Prev; 2007 Jun; 16(3):184-91. PubMed ID: 17415088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
    Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
    J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease.
    Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Hammar S
    N Engl J Med; 1996 May; 334(18):1150-5. PubMed ID: 8602180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CARET, the beta-carotene and retinol efficacy trial to prevent lung cancer in high-risk populations.
    Omenn GS
    Public Health Rev; 1991-1992; 19(1-4):205-8. PubMed ID: 1844268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation-derived Neutrophil-to-Lymphocyte Ratio and Lung Cancer Risk in Heavy Smokers.
    Grieshober L; Graw S; Barnett MJ; Thornquist MD; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA
    Cancer Prev Res (Phila); 2018 Nov; 11(11):727-734. PubMed ID: 30254071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.